Skip to main content
bioRxiv

Loss of the chromatin remodeler, ATRX, promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin receptor binding

Publication ,  Preprint
DeWitt, SB; Plumlee, SH; Brighton, H; Sivaraj, D; Martz, EJ; Zand, M; Kumar, V; Sheth, M; Floyd, W; Spruance, J; Hawkey, N; Varghese, S ...
2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

DOI

Publication Date

2022
 

Citation

APA
Chicago
ICMJE
MLA
NLM
DeWitt, S. B., Plumlee, S. H., Brighton, H., Sivaraj, D., Martz, E. J., Zand, M., … Eward, W. (2022). Loss of the chromatin remodeler, ATRX, promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin receptor binding. bioRxiv. https://doi.org/10.1101/2022.04.22.489086
DeWitt, Suzanne Bartholf, Sarah Hoskinson Plumlee, Hailey Brighton, Dharshan Sivaraj, E. J. Martz, Maryam Zand, Vardhman Kumar, et al. “Loss of the chromatin remodeler, ATRX, promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin receptor binding.” BioRxiv, 2022. https://doi.org/10.1101/2022.04.22.489086.
DeWitt SB, Plumlee SH, Brighton H, Sivaraj D, Martz EJ, Zand M, Kumar V, Sheth M, Floyd W, Spruance J, Hawkey N, Varghese S, Ruan J, Kirsch D, Somarelli J, Alman B, Eward W. Loss of the chromatin remodeler, ATRX, promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin receptor binding. bioRxiv. 2022.

DOI

Publication Date

2022